Contravisory Investment Management, Inc. Abbott Laboratories Transaction History

Contravisory Investment Management, Inc.

$453 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 13, 2023	SELL	$95.06 - $111.52 $296,967 - $348,388	-3,124 Reduced 82.78%	650 $0
Q3 2022 Oct 12, 2022	SELL	$96.76 - $112.03 $11,417 - $13,219	-118 Reduced 3.03%	3,774 $365,000
Q2 2022 Jul 13, 2022	SELL	$102.07 - $123.37 $9,084 - $10,979	-89 Reduced 2.24%	3,892 $423,000
Q1 2022 Apr 08, 2022	SELL	$114.02 - $139.04 $49,712 - $60,621	-436 Reduced 9.87%	3,981 $471,000
Q4 2021 Jan 12, 2022	BUY	$115.53 - $141.46 $51,988 - $63,657	450 Added 11.34%	4,417 $622,000
Q3 2021 Oct 12, 2021	SELL	$116.66 - $129.06 $6.9 Million - $7.64 Million	-59,177 Reduced 93.72%	3,967 $469,000
Q2 2021 Jul 14, 2021	SELL	$105.79 - $124.53 $135,199 - $159,149	-1,278 Reduced 1.98%	63,144 $7.32 Million
Q1 2021 Apr 14, 2021	SELL	$108.84 - $128.23 $234,767 - $276,592	-2,157 Reduced 3.24%	64,422 $7.72 Million
Q4 2020 Jan 13, 2021	BUY	$105.0 - $114.42 $19,740 - $21,510	188 Added 0.28%	66,579 $7.29 Million
Q3 2020 Oct 08, 2020	BUY	$91.64 - $111.29 $45,178 - $54,865	493 Added 0.75%	66,391 $7.23 Million
Q2 2020 Jul 09, 2020	BUY	$76.57 - $98.0 $132,542 - $169,638	1,731 Added 2.7%	65,898 $5.91 Million
Q1 2020 Apr 09, 2020	SELL	$62.82 - $91.86 $89,078 - $130,257	-1,418 Reduced 2.16%	64,167 $5.06 Million
Q4 2019 Jan 09, 2020	BUY	$78.51 - $87.4 $55,192 - $61,442	703 Added 1.08%	65,585 $5.7 Million
Q3 2019 Oct 07, 2019	SELL	$81.84 - $88.74 $45,830 - $49,694	-560 Reduced 0.86%	64,882 $5.43 Million
Q2 2019 Jul 09, 2019	SELL	$72.88 - $85.0 $248,593 - $289,935	-3,411 Reduced 4.95%	65,442 $5.5 Million
Q1 2019 Apr 08, 2019	SELL	$66.22 - $80.06 $176,741 - $213,680	-2,669 Reduced 3.73%	68,853 $5.5 Million
Q4 2018 Jan 14, 2019	SELL	$65.56 - $74.27 $59,987 - $67,957	-915 Reduced 1.26%	71,522 $5.17 Million
Q3 2018 Oct 11, 2018	SELL	$60.81 - $73.36 $161,389 - $194,697	-2,654 Reduced 3.53%	72,437 $5.31 Million
Q2 2018 Jul 11, 2018	BUY	$57.57 - $63.54 $4.27 Million - $4.71 Million	74,174 Added 8088.77%	75,091 $4.58 Million
Q3 2017 Oct 12, 2017	BUY	$48.06 - $53.64 $44,071 - $49,187	917	917 $49,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$20 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.6 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.13 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.82 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.34 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Contravisory Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Contravisory Investment Management, Inc. with notifications on news.

Account